Description
MK-3697 is a selective orexin 2 receptor antagonist.
Product Unit Size | Cost | Quantity | Stock |
---|
MK-3697 is a selective orexin 2 receptor antagonist.
Cas No. | 1224846-01-8 |
---|---|
Purity | ≥98% |
Formula | C23H21N5O3S |
Formula Wt. | 447.5 |
Chemical Name | N-[(5,6-dimethoxypyridin-2-yl)methyl]-2-(5-methylpyridin-3-yl)-5-(1,3-thiazol-2-yl)pyridine-4-carboxamide |
IUPAC Name | N-[(5,6-dimethoxypyridin-2-yl)methyl]-2-(5-methylpyridin-3-yl)-5-(1,3-thiazol-2-yl)pyridine-4-carboxamide |
Synonym | MK3697; M8238285OA; (2,3'-Bipyridine)-4-carboxamide, N-((5,6-dimethoxy-2-pyridinyl)methyl)-5'-methyl-5-(2-thiazolyl)- |
Solubility | Insoluble in water. DMSO (>20 mg/mL). |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
Info Sheet |
---|
Roecker AJ, Reger TS, Mattern MC. et.al. Discovery of MK-3697: a selective orexin 2 receptor antagonist (2-SORA) for the treatment of insomnia. Bioorg Med Chem Lett. (2014) 24:4884-90. PMID: 25248679 DOI: 10.1016/j.bmcl.2014.08.041.
STING antagonist
Corticosteroid; glucocorticoid agonist.
EGFR (T790M) inhibitor.
5-HT3 antagonist.
RXR agonist.
p53 activator, IMPDH and SIRT1 inhibitor.
GABA potentiator, voltage-gated Na+ and ATP-sen...
Ca2+-sensing receptor antagonist.
EGFR inhibitor.
Fermentation impurity
Antimicrobial found in essential oils from plan...
PI3K and mTOR inhibitor.
Regioisomers
Endogenous neuropeptide hormone, lowers extrace...
USP1 inhibitor
Endogenous anionic non-sulfated glycosaminoglyc...
Resveratrol prodrug; potential SIRT1 activator....
Steroid 5-α-reductase inhibitor.
Jumonji histone demethylase inhibitor.
Electron carrier used to study dehydrogenase el...